ovarian hyperstimulation syndrome
The Prevention of Ovarian Hyperstimulation Syndrome
... 7. Elective single embryo transfer is recommended in patients at high risk for ovarian hyperstimulation syndrome. (III-C) In patients undergoing controlled superovulation with pituitary suppression ...
10
The Diagnosis and Management of Ovarian Hyperstimulation Syndrome
... for ovarian hyperstimulation syndrome ...of ovarian hyperstimulation syndrome, the physician prescribing gonadotropins should ensure that women are made aware that they should ...
7
Ovarian cyst regression with levothyroxine in ovarian hyperstimulation syndrome associated with hypothyroidism
... Ovarian hyperstimulation syndrome (OHSS) is usually iatrogenic and is a potentially life-threatening com- plication of ovulation induction. Spontaneous OHSS might occur following high levels of human ...
5
Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma
... Ovarian hyperstimulation syndrome (OHSS) is a serious complication of controlled ovarian hyperstimulation ...The syndrome almost always presents either after hCG administration ...
5
Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer
... A 50 year old woman with breast cancer was diagnosed with ovarian hyperstimulation syndrome (OHSS) while taking tamoxifen. Tamoxifen-induced OHSS is rare. Furthermore, OHSS is very rare in the older ...
11
A new effective method in the treatment of severe ovarian hyperstimulation syndrome
... Background: Ovarian hyperstimulation syndrome (OHSS) is a recognized complication of ovulation induction, occurring in 1-10% of IVF and embryo transfer ...
6
Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation
... trigger. Ovarian response to gonadotropin was ...of ovarian follicles counted on day of hCG number of eggs retrieved and the incidence of ...OHSS. Ovarian hyperstimulation syndrome was ...
8
Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome
... Controlled ovarian hyperstimulation with gonadotropins is followed by Ovarian Hyperstimulation Syndrome (OHSS) in some women. An unidentified capillary permeability factor from the ...
9
CLINICAL PRACTICE GUIDELINE OVARIAN HYPERSTIMULATION SYNDROME (OHSS) DIAGNOSIS AND MANAGEMENT
... Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic systemic disease. The pathophysiology of OHSS, although not fully understood, is characterised by increased capillary permeability, leading ...
21
Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles
... to ovarian hyperstimulation syndrome (OHSS) none gave full embryological and clinical outcomes comparing oocyte trigger with human chorionic gonadotrophin (HCG) versus with a gonadotrophin-releasing ...
9
Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials
... 1. Ovarian hyperstimulation syndrome flow diagram for use in the clinical trial ...for ovarian hyperstimulation syndrome symptoms on the day of embryo transfer, the day of ...
27
<p>Can a cyclooxygenase inhibitor be an option for treatment of ovarian hyperstimulation syndrome?</p>
... Purpose: This study aimed to investigate the role of a cyclooxygenase inhibitor in ovarian hyperstimulation syndrome (OHSS) treatment and compare it with cabergoline. Materials and methods: A total ...
7
Ovarian hyperstimulation syndrome following surgical removal of a complete hydatidiform mole: a case report
... Generally, ovarian hyperstimulation syndrome develops after superovulation caused by ovulation- inducing drugs in infertile ...However, ovarian hyperstimulation syndrome ...
6
Clinical parameters of ovarian hyperstimulation syndrome (OHSS) following different triggers of oocyte maturation in IVF treatment
... that ovarian volumes following controlled ovarian stimu- lation recovered closer to baseline prestimulation volumes after GnRHa and kisspeptin than following hCG (ovarian volume was F I G U R E 1 ...
8
PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome
... of ovarian hyperstimulation ...severe ovarian hyperstimulation syndrome, all deemed avoidable due to definable breaches from the ...avoiding ovarian hyperstimulation ...
13
Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study
... on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome (OHSS) in an experimental ...and ovarian follicular reserve were assessed in all ...
6
Ovarian hyperstimulation syndrome and prophylactic human embryo cryopreservation: analysis of reproductive outcome following thawed embryo transfer
... Ovarian hyperstimulation syndrome (OHSS) is the most serious consequence of ovulation induction and in vitro fertilisation (IVF), potentially resulting in death in its extreme manifestation ...
6
Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)—a retrospective case–control study
... Methods: To assess whether polymorphisms of the VEGF/VEGF-receptor system contribute to the occurrence of ovarian hyperstimulation syndrome (OHSS), we performed a retrospective analysis of 116 OHSS ...
7
Interleukin-2 and SOCS-1 proteins involvement in the pathophysiology of severe ovarian hyperstimulation syndrome-a preliminary proof of concept
... Background: Ovarian hyperstimulation syndrome (OHSS), is characterized by marked ovarian enlargement and acute third space fluid sequestration that almost always develops after hCG ...
6
Original Article Risk factors, clinical manifestation and therapy strategy for ovarian hyperstimulation syndrome-a retrospective study of 358 patients
... Xue-Zhen Luo * , Hong-Mei Chen * , Hong-Yuan Jiang, Jin Zhu Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China. * Equal contributors. Received October 12, 2015; Accepted ...
6